# Azathioprine

## Asazipam 50mg

| TAH Drug Code      | [OASZ](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OASZ)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Adjuvant therapy for preventing rejection in kidney transplant surgery, systemic lupus erythematosus, severe rheumatoid arthritis, acute and chronic leukemia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | Organ transplantation: Adults and children - up to 5 mg/kg/day; maintenance: 1-4 mg/kg/ay. Other conditions:Adults and children - 1-3 mg/kg/day. If the patient continues to take the medication for 3 months without any improvement in symptoms, discontinuation may be considered.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Hypersensitivity to azathioprine or 6-mercaptopurine (6-MP). Pregnant or potentially pregnant patients. Patients with rheumatoid arthritis previously treated with alkylating agents.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Common: Nausea and vomiting (12%) Serious: Pericarditis, Skin cancer, Pancreatitis, Hypersensitivity, Acute myeloid leukemia, Hematologic toxicity, Leukopenia (Renal transplant, more than 50%; rheumatoid arthritis, 28%), Leukopenia (Severe), <2500 cells/mm[3] (renal transplant, 16%; rheumatoid arthritis, 5.3%), Macrocytic anemia, Myelodysplastic syndrome, Myelosuppression (5%), Pancytopenia, Thrombocytopenia, Hepatotoxicity (<1%), Lymphoma involves liver, Veno-occlusive disease of the liver, Hypersensitivity reaction, Malignant lymphoma (0.5%), T-cell lymphoma, Hepatosplenic, Progressive multifocal leukoencephalopathy, Adenocarcinoma of lung, Infectious disease (renal transplant, 20%; rheumatoid arthritis, <1%), Neoplastic disease (0.5-11.9%) |
| Pregnancy          | Human Data Suggest Risk in 3rd Trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

